{"entity":{"id":"nct01697384","kind":"trial","name":"Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer","aka":[],"tldr":"A phase 3 trial of Histrelin in Prostate cancer, run by Endo USA Inc., a Keenova Therapeutics Company, completed.","summary":"Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer is a phase 3 interventional study registered as NCT01697384 by Endo USA Inc., a Keenova Therapeutics Company, with 138 participants recorded, started 2000-04 and reaching its primary completion in 2003-08. Interventions recorded: histrelin acetate. Conditions recorded: Prostate Cancer, Adenocarcinoma of the Prostate.\n\nLinked to the drug Histrelin because the registry names it among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.","status":"completed","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT01697384","url":"https://clinicaltrials.gov/study/NCT01697384"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["prostate"],"sections":[],"technologies":[],"targets":[],"drugs":["histrelin"],"companies":["endo"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT01697384","phase":"3","setting":"Phase III, Open-Label Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Patients With Advanced Prostate Cancer","sponsor":"Endo USA Inc., a Keenova Therapeutics Company","enrolled":138,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct01697384/","neighbours":{"cancer":[{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"drug":[{"id":"histrelin","kind":"drug","name":"Histrelin","route":"/drugs/histrelin/"}],"company":[{"id":"endo","kind":"company","name":"Endo (now Keenova Therapeutics and Par Health)","route":"/companies/endo/"}]}}